Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Sanofi (SNYNF) Gross Margin (2016 - 2025)

Historic Gross Margin for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to 81.66%.

  • Sanofi's Gross Margin fell 16500.0% to 81.66% in Q4 2025 from the same period last year, while for Dec 2025 it was 63.28%, marking a year-over-year decrease of 140900.0%. This contributed to the annual value of 77.17% for FY2025, which is 15100.0% up from last year.
  • As of Q4 2025, Sanofi's Gross Margin stood at 81.66%, which was down 16500.0% from 78.02% recorded in Q3 2025.
  • Sanofi's Gross Margin's 5-year high stood at 83.31% during Q4 2024, with a 5-year trough of 39.54% in Q2 2025.
  • For the 5-year period, Sanofi's Gross Margin averaged around 73.4%, with its median value being 74.48% (2023).
  • In the last 5 years, Sanofi's Gross Margin plummeted by -5971900bps in 2021 and then skyrocketed by 85300bps in 2024.
  • Sanofi's Gross Margin (Quarter) stood at 69.44% in 2021, then increased by 4bps to 72.0% in 2022, then rose by 4bps to 74.78% in 2023, then increased by 11bps to 83.31% in 2024, then decreased by -2bps to 81.66% in 2025.
  • Its last three reported values are 81.66% in Q4 2025, 78.02% for Q3 2025, and 39.54% during Q2 2025.